Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy
- 30 May 2002
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 186 (1), 1-9
- https://doi.org/10.1016/s0304-3835(02)00258-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Treatment of Malignancy by Activation of the Plasminogen SystemSeminars in Thrombosis and Hemostasis, 2002
- Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasisProceedings of the National Academy of Sciences, 2002
- Changes of the Coagulation and Fibrinolysis System in Malignancy: Their possible Impact on Future Diagnostic and Therapeutic Procedurescclm, 2000
- Intraoperativelym-administered aprotinin and survival after elective liver resection for colorectal cancer metastasis A preliminary studyFibrinolysis and Proteolysis, 1999
- Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer SpreadThrombosis and Haemostasis, 1999
- Heparin and CancerThrombosis and Haemostasis, 1998
- Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.Journal of Clinical Oncology, 1997
- Pathways of Coagulation/Fibrinolysis Activation in MalignancySeminars in Thrombosis and Hemostasis, 1992
- A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.Journal of Clinical Oncology, 1989
- Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75JAMA, 1981